Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from NEJM

Debunking the 100,000 Medicaid Deaths Myth

Partisan pundits are misreading statistical estimates and misrepresenting the science to suggest that Trump's Medicaid cuts will kill 100,000 people. That claim doesn’t survive scrutiny.

Reason

Satya Nadella Says Microsoft's AI 'Orchestrator' Beats Human Doctors On Tough Diagnoses — What This Means For The Future of Healthcare

On Monday, Microsoft Corporation (NASDAQ:MSFT) CEO Satya Nadella unveiled an AI system that outperforms human doctors in diagnosing complex medical cases, signaling a major leap toward “medical superintelligence.”

Benzinga

Microsoft says AI system better than doctors at diagnosing complex health conditions

Firm says results of research create ‘path to medical superintelligence’ but plays down job implications

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

'Game changer' diabetes pill a step closer after trials

A new type of diabetes pill has been shown to act in a similar way to injectable treatments like Ozempic, with more like it in the pipeline.

AAP

RFK Jr Issues Ultimatum to Medical Journals: 'Change Dramatically' or Fed Scientists Will Publish Elsewhere

HHS Secretary RFK Jr. threatened top medical journals, warning that NIH scientists could be barred from publishing in what he called "corrupt" publications

Latin Times

‘They’re all corrupt!’: RFK Jr. threatens to pull government scientists from top medical journals

Losing scientists one day at a time.

We Got This Covered

HIV prevention medication ‘could one day be a yearly jab’ – study suggests

Yearly doses could reduce barriers people face to taking preventative HIV medication, researchers said.

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

Designer immune-cell therapy could shrink deadly brain tumors, early trials show

Two early clinical trials that together included nine patients suggest that a treatment called CAR-T therapy could treat glioblastoma, but its long-term effects are unknown.

LiveScience

The growing case for doing less: How harmless cancers are being overdiagnosed in America

The pattern extends to multiple cancers, including those affecting the breast, prostate, melanoma, and thyroid.

Fortune

Could an antibiotic taken after unprotected sex prevent STIs? What to know about doxy-PEP.

This summer, the CDC is expected to release guidelines for the use of doxy-PEP to prevent STIs. But what is it, and why is everyone talking about it now?

LiveScience

13 horrific firework injuries that will keep you cautious on July 4

As July Fourth celebrations take off across the U.S., so will the number of firework-related accidents and hospital visits.

LiveScience

The truth about MSG, a much-maligned source of great flavour

Is MSG the cause of an allergy? Is it a public menace? If so - and the bulk of evidence says it isn't - it's many foods you eat every day.

The New Daily

New Alzheimer's drug shows modest slowing of early disease progression

Scientists are cautiously optimistic about the promise of an experimental drug shown to modestly slow the progression of Alzheimer's disease in some patients.

ABC News

Newly identified Langya virus tracked after China reports dozens of cases

Virus, which causes symptoms including fever, fatigue, cough, loss of appetite and muscle aches, is believed to have spread from animals to humans

The Guardian - AU

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Ionis Pharma Announces Publication Of Positive Donidalorsen Data For Angioedema Attacks

Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced the publication of Phase 2 data for donidalorsen in the New England Journal of Medicine (NEJM). Donidalorsen is an investigational antisense medicine under development for hereditary angioedema (HAE), a disorder characterized by recurrent episodes of severe swelling. In the Phase 2 study, donidalorsen demonstrated a 90% reduction in…

Benzinga

GSK/Vir Biotech's COVID-19 Antibody Associated With Resistance Mutations, New Research Shows

According to new research in Australia, some people have developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline Plc (NYSE:GSK) and Vir Biotechnology Inc (NASDAQ:VIR) monoclonal antibody with COVID-19 infection. Data shows that the mutations have been associated with a reduction by a factor of 100 to 297 in neutralization by sotrovimab. "These data show the persistence…

Benzinga

NEJM Publication Shows Novartis' Kisqali With Longest Median Overall Survival In Breast Cancer Setting

The New England Journal of Medicine (NEJM) published data from Phase 3 MONALEESA-2 trial of Novartis AG's (NYSE:NVS) Kisqali (ribociclib) plus letrozole demonstrating a statistically significant improvement in overall survival. MONALEESA-2 overall survival data were first presented at the European Society for Medical Oncology Congress in September 2021. The NEJM publication includes additional analyses substantiating the longest median…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Microsoft Corporation

271 stories

Lancet

179 stories

University of Chicago

New England Journal of Medicine

31 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.